JIN MED INTL LTD. Stock Price, News & Analysis

Jin Medical International Ltd. (Nasdaq: ZJYL) is a Cayman Islands holding company with Chinese operating entities in the surgical and medical instrument manufacturing industry. Through these operating entities, the company designs, develops, manufactures and markets wheelchairs, rehabilitation medical equipment and living aids products for people with disabilities, elderly users and individuals undergoing rehabilitation or recovering from injuries. Founded in 2006 and headquartered in Changzhou City, Jiangsu Province, China, Jin Medical focuses on rehabilitation equipment and related health products that support mobility, daily living and wellness.

Core business and products

According to company disclosures, Jin Medical’s Chinese operating entities manufacture manual wheelchairs, electric wheelchairs, wheelchair components and other living aids products. The majority of its wheelchair products, covering more than 30 models, are sold to distributors and dealers in Japan and China. These include sales to Nissin Medical Industries Co., Ltd., which Jin Medical describes as one of the largest medical device distributors in Japan. The company states that its wheelchair designs emphasize being lightweight and ergonomic, and that it aims to deliver new wheelchair designs each year.

Beyond wheelchairs, Jin Medical reports that its product portfolio has expanded to include walking aids, breathing medical equipment, intelligent nano bath equipment, portable nano-thermal therapy baths, micro-hyperbaric oxygen chambers, hydrogen generation machines, and lifestyle beauty and body products. The beauty-related equipment described by the company includes facial management equipment, slimming fat burning equipment and health management equipment. Jin Medical also refers to Leyu series products, fitness equipment for the elderly and special groups, and disaster relief products, as part of its broader rehabilitation and health-related offerings.

Manufacturing footprint and capacity

Jin Medical’s Chinese operating entities operate two manufacturing plants in Changzhou City and Taizhou City, Jiangsu Province, with an aggregate area of approximately 228,000–230,000 square feet, based on company descriptions. The company has also reported the establishment of a new manufacturing facility in Chuzhou City, Anhui Province, China. This Chuzhou facility is described as an internationally standardized, high-end wheelchair and electric wheelchair manufacturing factory, with production lines for manual wheelchairs, electric wheelchairs, electric scooters, micro hyperbaric chambers and certain healthcare and cosmetic products.

In a subsequent update, Jin Medical reported that its wholly owned subsidiary ZhongJin Medical Equipment (Anhui) Co., Ltd. launched production at Plant No. 3 of its intelligent manufacturing facility in Chuzhou. The company states that this facility is designed with an annual production capacity of approximately 200,000 units and that it incorporates robotic arms, temperature-controlled workshops and laser-welded aluminum-alloy frames. Jin Medical links this capacity to its goal of accelerating integration of the global rehabilitation device supply chain and supporting expansion across regional markets.

Distribution network and markets

Jin Medical reports that its Chinese operating entities have established relationships with more than 40 distributors in China and more than 20 distributors in other regions where its products are sold. The company states that the majority of its wheelchair products are sold to dealers in Japan and China, and that it has worked with partners such as Nissin Medical Industries Co., Ltd. in Japan. In other disclosures, Jin Medical notes that its products are supplied to senior care communities, rehabilitation centers and home clinics in locations such as Istanbul, Jerusalem and Tokyo through its electric wheelchair offerings.

In addition to traditional distributor channels, Jin Medical has highlighted cooperation opportunities in the medical equipment sharing space. A memorandum of understanding with Jiangsu Zhongjin Kanglu Information Technology Co., Ltd. describes a medical equipment sharing business that deploys shared wheelchairs, emergency carts and companion beds in hospitals across China. Jin Medical views this type of platform as a way to create synergies for promoting its products in the domestic market.

Rehabilitation and health technology focus

Company statements emphasize a focus on rehabilitation technology, assistive technologies and health-related equipment. Jin Medical describes itself as an industrial leader in assistive technologies and as a provider of rehabilitation medical equipment. It highlights principles such as “care in every product” and the integration of comfort and design backed by medical research. The company reports owning a number of patents with the Patent Administration Department of the People’s Republic of China, including invention and utility model patents related to nano bathing products.

The company’s micro-hyperbaric oxygen chambers and nano-thermal therapy bath products are positioned by Jin Medical as health and wellness devices. The micro-hyperbaric oxygen chambers are described as low-pressure, high-safety equipment intended for groups such as the elderly, patients with chronic diseases, beauty-focused users, people with compromised health, athletes, obese individuals and postoperative rehabilitation patients. Jin Medical states that these chambers are designed for daily oxygen protection, health improvement, postoperative recovery, immunity enhancement and anti-aging effects. The portable nano-thermal therapy bath is described as using nano-water particle thermal therapy to provide a non-immersive bathing experience aimed at relaxation, comfort and skin benefits for elderly and physically weakened users.

Strategic collaborations and projects

Jin Medical has reported several notable collaborations and projects. In the lifestyle beauty products segment, the company established a Beauty Products Division and collaborated with Japanese beauty product manufacturer MIYAKO to develop facial management equipment, slimming fat burning equipment and health management equipment. The company has disclosed initial orders for these products from Avant Beauty Biotech (Shanghai) Co., Ltd., which plans to deploy the equipment in the Chinese market and has indicated potential overseas sales.

In the healthcare and elderly care space, Jin Medical’s portable nano-thermal therapy bath was selected as equipment for the “Lao Le Hui” Assisted Bathing Project in Shanghai. This project aims to serve disabled or semi-disabled elderly individuals through community-based service centers, and Jin Medical’s role includes providing nano-thermal therapy bath equipment and auxiliary medical devices. The company presents this initiative as both a philanthropic effort and an opportunity to further commercialize its bath products.

Jin Medical has also announced significant orders for its S-type and M-type micro-hyperbaric oxygen chambers from Conlo Industrial Development (Shanghai) Co., Ltd., and has described Conlo’s plans to deploy large numbers of oxygen chambers for human and pet use in the Chinese market over a multi-year period. These disclosures illustrate how Jin Medical seeks to extend its reach beyond traditional wheelchair products into broader health and wellness applications.

Capital markets and regulatory status

Jin Medical’s ordinary shares trade on the Nasdaq Capital Market under the symbol ZJYL. The company has filed reports on Form 6-K and maintains a registration statement on Form F-3 with the U.S. Securities and Exchange Commission. In a notification dated May 2, 2025, Nasdaq informed the company that it was not in compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Capital Market. Jin Medical disclosed that this notice had no immediate effect on the listing of its ordinary shares and that it was granted an initial 180-day period to regain compliance, with the possibility of an additional compliance period subject to certain conditions. The company has stated that it intends to monitor its share price and evaluate options, including a potential reverse stock split, while noting that there is no assurance of regaining or maintaining compliance.

Separately, in September 2023, Jin Medical reported receiving a Nasdaq notification that it no longer complied with the requirement to maintain a minimum of 300 public holders under Nasdaq Listing Rule 5550(a)(3). The company indicated that it would submit a plan to regain compliance and could receive an extension period if the plan were accepted. These disclosures highlight listing-related considerations that investors may wish to review in the company’s SEC filings and Nasdaq communications.

Corporate structure and governance

Jin Medical describes itself as a Cayman Islands holding company whose business is conducted through Chinese operating entities. These entities were founded in 2006 and are headquartered in Changzhou City, Jiangsu Province. The company’s SEC filings note that it files annual reports on Form 20-F as a foreign private issuer and furnishes interim financial information on Form 6-K, including unaudited condensed consolidated financial statements and management’s discussion and analysis for six-month periods.

In a June 2025 Form 6-K, Jin Medical reported the appointment of an independent director to its board of directors, who also serves as chairperson of the Nominating and Corporate Governance Committee and as a member of the Audit and Compensation Committees. The company describes this director as having experience in finance, investment, healthcare and academic research, and notes his background in overseeing financial operations, SEC compliance and cross-border mergers and acquisitions.

Research, development and intellectual property

Jin Medical emphasizes research and development as a key element of its business. The company refers to provincial engineering technology research centers, provincial industrial technology centers and cooperation with R&D institutions and enterprises in the field of rehabilitation. It states that its Chinese operating entities own a number of patents registered with the Patent Administration Department of the People’s Republic of China, including patents for nano bathing products. Company communications repeatedly highlight technological innovation as a driver of product development and market expansion.

Position within the rehabilitation and assistive technology sector

Within the broader manufacturing sector, Jin Medical operates in the niche of rehabilitation and assistive technologies, focusing on equipment that supports mobility, daily living and wellness for elderly users, people with disabilities and individuals recovering from illness or injury. The company’s descriptions of its activities include manual and electric wheelchairs, shared wheelchair infrastructure, oxygen therapy equipment, nano-thermal bathing systems and lifestyle beauty and health devices. By combining manufacturing capacity in China with distributor networks in Japan, China and other regions, Jin Medical positions itself as a participant in both domestic and international markets for rehabilitation and health-related equipment.

Use cases and end users

Based on company statements, Jin Medical’s products are intended for use by a range of end users and institutions. Wheelchairs and living aids products are designed for people with disabilities, the elderly and rehabilitation patients. Shared wheelchair and medical equipment programs are deployed in hospitals and healthcare institutions to address equipment availability and leasing challenges. Micro-hyperbaric oxygen chambers and nano-thermal therapy baths are described as suitable for elderly individuals, people with chronic conditions, beauty-focused consumers, athletes and postoperative patients. Lifestyle beauty equipment is aimed at users seeking facial care, body shaping and posture or musculoskeletal support, with deployment through leasing and related service channels.

Key considerations for investors and observers

Investors and observers reviewing Jin Medical may wish to consider the company’s concentration in rehabilitation and health-related equipment manufacturing, its reliance on distributor networks in Japan and China, and its ongoing efforts to expand into new product categories such as micro-hyperbaric oxygen chambers and lifestyle beauty devices. Company disclosures regarding Nasdaq listing compliance, capital market activities and governance developments are available in its SEC filings, including Forms 20-F and 6-K. As with any listed issuer, these documents provide additional detail on financial performance, risk factors, operational trends and corporate structure.